Patents by Inventor Nicolas Muzet

Nicolas Muzet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrimidinone derivatives as antimalarial agents
    Patent number: 9321790
    Abstract: The invention relates to novel pyrimidinone-based heterocyclic compounds which are parasite growth inhibitors, having the general formula (I) in which Y is a morpholine chosen from three bridged morpholines, L is a bond or a linker, n=0 or 1 and R2 is a methyl group when n=0 and a hydrogen atom when n=1. Process for the preparation thereof and therapeutic use thereof.
    Type: Grant
    Filed: June 21, 2013
    Date of Patent: April 26, 2016
    Assignee: Sanofi
    Inventors: Youssef El-Ahmad, Bruno Filoche-Romme, Axel Ganzhorm, Gilbert Marciniak, Nicolas Muzet, Baptiste Ronan, Bertrand Vivet, Véronique Zerr
  • Pyrimidooxazocine derivatives as mTOR-inhibitors
    Patent number: 9120812
    Abstract: The invention relates to bicyclic heterocyclic derivatives of general formula (I) to a process for preparing them and to the therapeutic use thereof.
    Type: Grant
    Filed: January 25, 2013
    Date of Patent: September 1, 2015
    Assignee: Sanofi
    Inventors: Alain Braun, Olivier Crespin, Yann Foricher, Gilbert Marciniak, Nicolas Muzet, Eric Nicolai, Cecile Pascal, Bertrand Vivet, Fabrice Viviani
  • Pyrimidinone Derivatives as Antimalarial Agents
    Publication number: 20150183804
    Abstract: The invention relates to novel pyrimidinone-based heterocyclic compounds which are parasite growth inhibitors, having the general formula (I) in which Y is a morpholine chosen from three bridged morpholines, L is a bond or a linker, n=0 or 1 and R2 is a methyl group when n=0 and a hydrogen atom when n=1. Process for the preparation thereof and therapeutic use thereof.
    Type: Application
    Filed: June 21, 2013
    Publication date: July 2, 2015
    Inventors: Youssef El-Ahmad, Bruno Filoche-Romme, Axel Ganzhorm, Gilbert Marciniak, Nicolas Muzet, Baptiste Ronan, Bertrand Vivet, Véronique Zerr
  • PYRIMIDOOXAZOCINE DERIVATIVES AS MTOR - INHIBITORS
    Publication number: 20140378433
    Abstract: The invention relates to bicydic heterocyclic derivatives of general formula (I) to a process for preparing them and to the therapeutic use thereof.
    Type: Application
    Filed: January 25, 2013
    Publication date: December 25, 2014
    Applicant: SANOFI
    Inventors: Alain Braun, Olivier Crespin, Yann Foricher, Gilbert Marciniak, Nicolas Muzet, Eric Nicolai, Cecile Pascal, Bertrand Vivet, Fabrice Viviani
  • Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof
    Patent number: 8242126
    Abstract: The invention relates to quinazolinedione derivatives of the general formula (I): wherein A, R1, R2, R3, R4, m, n, p, p?, and r are as defined herein, processes for the preparation thereof and their therapeutic applications.
    Type: Grant
    Filed: April 5, 2010
    Date of Patent: August 14, 2012
    Assignee: Sanofi
    Inventors: Annie Clauss, Christophe Glaess, Gilbert Marciniak, Nicolas Muzet, Jean-Francois Nave, André Seyer, Bertrand Vivet
  • QUINAZOLINEDIONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USES THEREOF
    Publication number: 20100298298
    Abstract: The invention relates to quinazolinedione derivatives, processes for the preparation thereof and their therapeutic applications.
    Type: Application
    Filed: April 5, 2010
    Publication date: November 25, 2010
    Applicant: SANOFI-AVENTIS
    Inventors: Annie CLAUSS, Christophe GLAESS, Gilbert MARCINIAK, Nicolas MUZET, Jean-Francois NAVE, André SEYER, Bertrand VIVET